Enzene’s new R&D facility, spanning over 75,000 square feet, is equipped with an open lab set-up that promotes cross-departmental collaboration, efficient communication, and knowledge sharing
Enzene Biosciences, a leading biopharmaceutical company offering integrated Contract Development and Manufacturing (CDMO) services for biologics, announced the inauguration of its research and development (R&D) facility in Pune.
Enzene’s new R&D facility, spanning over 75,000 square feet, is equipped with an open lab set-up that promotes cross-departmental collaboration, efficient communication, and knowledge sharing. This facility marks a significant milestone in the company’s commitment to fostering innovation and advancing the frontiers of biotechnology. The facility showcases Enzene’s dedication to advancing scientific research and development, offering fully integrated services from Cell Line Development to Fill and finish across a wide range of modalities. By breaking down traditional barriers, Enzene aims to facilitate seamless cross-functional interactions, which are proven to spark creativity and drive innovation.
Located in the Chakan Industrial Area of Pune, represents a major investment in the pursuit of scientific excellence. Within the new R&D facility, Enzene has established specialized departments, including Cell Line Engineering (CLE), Drug Product Development (DPD), Purification Process Development (PPD), Advanced Analytical Technology (AAT), and Bioanalytical Assay, the company stated.
